ANGIODYNAMICS INC - 8-K Filing
AngioDynamics reports Q1 FY2027 results with Med Tech segment growth and announces new CEO (Items: 2.02 of this Form 8-K (including Exhibit 99, 7.01 of this Form 8-K (including Exhibit 99)
Tickers: $ANGO
AngioDynamics reports Q1 FY2027 results with Med Tech segment growth and announces new CEO (Items: 2.02 of this Form 8-K (including Exhibit 99, 7.01 of this Form 8-K (including Exhibit 99)
Tickers: $ANGO